CSI Market
Sign In | Register

Vycor Medical Inc (VYCO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VYCO Annual Cash Flow →
From Vycor Medical Inc through Jun 30 2025, changes in Jun 30 2026's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-0.17
Depreciation & amortization0.06
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.01
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total0.00
Shares Based Interest Expense-
Increase Decrease Accrued Interest Related Party-
Gain Loss On Extension Of Warrants-
Conversion Of Stock Amount Converted-
Amount Paid For Acquisition Of Subsidiary-
Inventory For Provision-
Interest Income Related Party-
Increase Decrease Accrued Interest Other-
Inventory Provision-
Increase Decrease In Interest Payable Related Party Net-0.12
Income taxes0.00
Gain (Loss) on Sale of Properties0.00
Increase (Decrease) in Accounts Receivable-0.01
Accounts Payable-0.02
Accrued Expense0.03
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense-0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.21
Discontinued operations0.00
Net Cash flow from Operating Activities0.09
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Payments for (Proceeds from) Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Website-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.02
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.05
Net Proceeds From Issuance Of Preferred Stock-
Purchase Of Shares Into Treasury Stock-
Repayment Of Notes Payble Related Party-
Monies In Escrow Related Party Private Placement-
Monies In Escrow Related Party Offerings-
Proceeds From Paycheck Protection Program And E I D L-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow0.10
Total Cash Flow0.07
4 historic quarters locked

Sign in to unlock the full Vycor Medical Inc cash flow history.

Sign In Create Free Account

About Vycor Medical Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-038349

Figures are derived from filed reports and may be restated. Historical data is subject to revision.